Business Description
Shijiazhuang Yiling Pharmaceutical Co Ltd
NAICS : 325412
SIC : 2834
ISIN : CNE1000015S0
Share Class Description:
SZSE:002603: Class ACompare
Compare
Traded in other countries / regions
002603.China IPO Date
2011-07-28Description
Shijiazhuang Yiling Pharmaceutical Co Ltd is a China-based company engages in the pharmaceutical manufacturing. The company is principally engaged in the research, development, manufacturing, and sales of traditional Chinese pharmaceutical products, especially in the fields of cardiovascular and cerebrovascular diseases, respiratory diseases, tumor, diabetes and related complications. Its products include innovative drug series, chemical drugs, Chinese medicine series, and health products.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.92 | |||||
| Equity-to-Asset | 0.69 | |||||
| Debt-to-Equity | 0.12 | |||||
| Debt-to-EBITDA | 2.22 | |||||
| Interest Coverage | 17.08 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | 4.87 | |||||
| Beneish M-Score | -1.81 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 5.5 | |||||
| 3-Year EBITDA Growth Rate | 10.4 | |||||
| 3-Year EPS without NRI Growth Rate | 2.6 | |||||
| 3-Year Book Growth Rate | 9 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 25.24 | |||||
| 9-Day RSI | 30.05 | |||||
| 14-Day RSI | 32.83 | |||||
| 6-1 Month Momentum % | -9.23 | |||||
| 12-1 Month Momentum % | -35.91 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.55 | |||||
| Quick Ratio | 1.09 | |||||
| Cash Ratio | 0.3 | |||||
| Days Inventory | 209.75 | |||||
| Days Sales Outstanding | 95.43 | |||||
| Days Payable | 231.93 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.66 | |||||
| Dividend Payout Ratio | 1.66 | |||||
| 3-Year Dividend Growth Rate | 51.8 | |||||
| Forward Dividend Yield % | 2.66 | |||||
| 5-Year Yield-on-Cost % | 25.05 | |||||
| 3-Year Average Share Buyback Ratio | 0.3 | |||||
| Shareholder Yield % | 0.75 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 52.24 | |||||
| Operating Margin % | 8.14 | |||||
| Net Margin % | 5.1 | |||||
| FCF Margin % | -4.43 | |||||
| ROE % | 3.85 | |||||
| ROA % | 2.58 | |||||
| ROIC % | 4.32 | |||||
| ROC (Joel Greenblatt) % | 7.84 | |||||
| ROCE % | 5.02 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 69.23 | |||||
| PE Ratio without NRI | 62.35 | |||||
| Shiller PE Ratio | 31.18 | |||||
| PEG Ratio | 2.39 | |||||
| PS Ratio | 3.53 | |||||
| PB Ratio | 2.68 | |||||
| Price-to-Tangible-Book | 2.94 | |||||
| EV-to-EBIT | 49.42 | |||||
| EV-to-EBITDA | 49.42 | |||||
| EV-to-Revenue | 3.55 | |||||
| EV-to-FCF | -79.96 | |||||
| Price-to-Projected-FCF | 1.95 | |||||
| Price-to-DCF (Earnings Based) | 1.99 | |||||
| Price-to-Median-PS-Value | 0.82 | |||||
| Price-to-Peter-Lynch-Fair-Value | 2.49 | |||||
| Price-to-Graham-Number | 2.85 | |||||
| Price-to-Net-Current-Asset-Value | 24.45 | |||||
| Earnings Yield (Greenblatt) % | 2.02 | |||||
| FCF Yield % | -1.26 | |||||
| Forward Rate of Return (Yacktman) % | 21.81 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Shijiazhuang Yiling Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 8,905.99 | ||
| EPS (TTM) (Â¥) | 0.272 | ||
| Beta | 0.96 | ||
| Volatility % | 27.77 | ||
| 14-Day RSI | 32.83 | ||
| 14-Day ATR (Â¥) | 0.465832 | ||
| 20-Day SMA (Â¥) | 19.6455 | ||
| 12-1 Month Momentum % | -35.91 | ||
| 52-Week Range (Â¥) | 17.8 - 33.29 | ||
| Shares Outstanding (Mil) | 1,670.71 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Shijiazhuang Yiling Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Shijiazhuang Yiling Pharmaceutical Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Shijiazhuang Yiling Pharmaceutical Co Ltd Frequently Asked Questions
What is Shijiazhuang Yiling Pharmaceutical Co Ltd(SZSE:002603)'s stock price today?
The current price of SZSE:002603 is ¥18.83. The 52 week high of SZSE:002603 is ¥33.29 and 52 week low is ¥17.80.
When is next earnings date of Shijiazhuang Yiling Pharmaceutical Co Ltd(SZSE:002603)?
The next earnings date of Shijiazhuang Yiling Pharmaceutical Co Ltd(SZSE:002603) is .
Does Shijiazhuang Yiling Pharmaceutical Co Ltd(SZSE:002603) pay dividends? If so, how much?
The Dividend Yield %  of Shijiazhuang Yiling Pharmaceutical Co Ltd(SZSE:002603) is 2.66% (As of Today), Highest Dividend Payout Ratio of Shijiazhuang Yiling Pharmaceutical Co Ltd(SZSE:002603) was 1.66. The lowest was 0.13. And the median was 0.21. The  Forward Dividend Yield % of Shijiazhuang Yiling Pharmaceutical Co Ltd(SZSE:002603) is 2.66%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers